Literature DB >> 35913631

Need for adjuvant radiotherapy in oral cancer: depth of invasion rather than tumor diameter.

Cosima E Riemenschnitter1, Grégoire B Morand2, Charlotte S Schouten2, Niels J Rupp3, Panagiotis Balermpas4, Thomas Gander5, Martina A Broglie Däppen2.   

Abstract

PURPOSE: The 8th edition of the TNM Cancer Staging Manual incorporates depth of invasion (DOI) into the pathologic tumor classification for oral squamous cell carcinoma (OSSC). While deep invading tumors with small tumor diameters (TD) have been categorized as early stage tumors in the 7th edition, they are now upstaged, potentially influencing the decision to initiate adjuvant radiotherapy (RT).
METHODS: OSCC patients surgically treated with curative intent between 2010 and 2019 were consecutively included. Tumors were staged based on TD only (according to the 7th edition TNM Cancer Staging Manual), then restaged based solely on DOI.
RESULTS: Of the 133 included patients, 58 patients (43.6%) had a different pT-stage when using DOI instead of TD for staging (upstaging in 23.3%). Overall survival (OS) was significantly worse in patients who were upstaged with DOI. In addition, stratification by adjuvant RT showed significant worse OS in upstaged patients without receiving adjuvant RT.
CONCLUSIONS: DOI seems to be an import indicator for adjuvant RT in OSCC-patients.
© 2022. The Author(s).

Entities:  

Keywords:  Carcinoma, squamous cell; Mouth neoplasms; Neoplasm recurrence, local; Neoplasm staging; Otolaryngology; Radiotherapy, adjuvant

Year:  2022        PMID: 35913631     DOI: 10.1007/s00405-022-07561-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   3.236


  1 in total

1.  Invasion characteristics of oral tongue cancer: frequency of reporting and effect on survival in a population-based study.

Authors:  Michael Goodman; Lihua Liu; Kevin Ward; Juanjuan Zhang; Lyn Almon; Gan Su; Lenard Berglund; Amy Chen; Uttam K Sinha; John L Young
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.